Trujillo, J. A., Sweis, R. F., Bao, R., & Luke, J. J. (2018). T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer immunology research, 6(9), 990. https://doi.org/10.1158/2326-6066.CIR-18-0277
Chicago Style (17th ed.) CitationTrujillo, Jonathan A., Randy F. Sweis, Riyue Bao, and Jason J. Luke. "T Cell-Inflamed Versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection." Cancer Immunology Research 6, no. 9 (2018): 990. https://doi.org/10.1158/2326-6066.CIR-18-0277.
MLA (9th ed.) CitationTrujillo, Jonathan A., et al. "T Cell-Inflamed Versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection." Cancer Immunology Research, vol. 6, no. 9, 2018, p. 990, https://doi.org/10.1158/2326-6066.CIR-18-0277.